13F-HR filed by PATHWAY CAPITAL MANAGEMENT, LP
PATHWAY CAPITAL MANAGEMENT, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-13, with 6 holding rows worth $18,041,000.
- Accession
- 0001214659-21-005256
- Filer
- CIK 1037353
- Filed
- 2021-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 6 entries on the cover page, a total value of $18,041,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $18,041,000 with VALUE read as thousands by filing date, 13F file number 028-19862. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROBLOX CORP CL A | 771049103 | Stock | 131,036 | $8,495,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 54,946 | $3,213,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 37,399 | $2,993,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 47,255 | $2,423,000 | thousands by filing date | |
| PDD HOLDINGS INC SPONSORED ADS | 722304102 | ADR | 5,151 | $690,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 8,562 | $227,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-21-005256 | this filing | 2021-05-13 | acceptance time not in the bulk data set |